Cargando…
Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
Duchenne muscular dystrophy (DMD) is an X-linked recessive, infancy-onset neuromuscular disorder characterized by progressive muscle weakness and atrophy, leading to delay of motor milestones, loss of autonomous ambulation, respiratory failure, cardiomyopathy, and premature death. DMD originates fro...
Autores principales: | Manini, Arianna, Abati, Elena, Nuredini, Andi, Corti, Stefania, Comi, Giacomo Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797140/ https://www.ncbi.nlm.nih.gov/pubmed/35095747 http://dx.doi.org/10.3389/fneur.2021.814174 |
Ejemplares similares
-
Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
por: Abati, Elena, et al.
Publicado: (2021) -
Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
por: Abati, Elena, et al.
Publicado: (2022) -
Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies
por: Piga, Daniela, et al.
Publicado: (2019) -
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
por: Duan, Dongsheng
Publicado: (2018) -
Neurocognitive Profiles in Duchenne Muscular Dystrophy and Gene Mutation Site
por: D’Angelo, Maria Grazia, et al.
Publicado: (2011)